11:14 AM EDT, 05/06/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending modestly lower late Tuesday morning, declining 0.26% to 1,416.22 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Cellectis ( CLLS ) , which rose 5.1% each. They were followed by telecommunications operator Telefonica ( TEF ) and petroleum refiner Equinor ( EQNR ) , which increased 1.8% each.

The decliners from continental Europe were led by accommodations booking company trivago (TRVG) and electronics conglomerate Philips (PHG), which fell 4.4% and 3.9% respectively. They were followed by furniture maker Natuzzi (NTZ) and pharmaceutical company Novo Nordisk ( NVO ) , which dropped 3.4% and 3.1% respectively.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and alcoholic beverage company Diageo ( DEO ) , which were up 3.3% and 2.1% respectively. They were followed by financial services company Lloyds Banking Group ( LYG ) and tobacco company British American Tobacco ( BTI ) , which advanced 1.3% and 1.1% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana ( NCNA ) and Bicycle Therapeutics ( BCYC ) , which lost 68% and 4.3% respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which were down 3.8% and 2.8% respectively.